In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95

Identification of Bacteroides thetaiotaomicron on the basis of an unexpected specific amplicon of universal 16S ribosomal DNA PCR. J Clin Microbiol (2004) 0.84

Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol (2010) 0.83

Prevalence and antibiotic susceptibility of Bacteroides fragilis group isolated from stool samples in North Lebanon. Braz J Microbiol (2014) 0.75

Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83

Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45

Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis (1996) 1.87

Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis (2000) 1.83

Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother (2001) 1.79

Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin Infect Dis (1995) 1.76

Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Clin Infect Dis (1993) 1.59

Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother (1999) 1.38

Susceptibility testing of anaerobic bacteria. J Clin Microbiol (1988) 1.27

The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections. Am J Surg (1995) 1.22

Bacteroides species highly resistant to metronidazole: an emerging clinical problem? Clin Microbiol Infect (1999) 1.21

A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. Diagn Microbiol Infect Dis (1994) 1.15

High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates. J Antimicrob Chemother (2000) 1.02

Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics (2004) 1.82

Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis (2004) 1.79

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. Vaccine (2007) 1.55

The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis (2005) 1.26

Parental perspectives on influenza vaccination among children with asthma. Public Health Rep (2006) 1.23

Ending inequities in access to effective pain relief? Lancet (2010) 1.09

Peer and sibling substance use: predictors of substance use among adolescents in Mexico. Rev Panam Salud Publica (2004) 1.04

Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns. Antimicrob Agents Chemother (2003) 0.93

Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta protein. Cancer Cell Int (2009) 0.86

Substance use among school-based youths in northern Mexico. Am J Addict (2005) 0.83

Evidence of a substantial decline in prevalence of HIV-1 infection among pregnant women: data from 1995 to 2003 in Dar es Salaam, Tanzania. Scand J Public Health (2006) 0.83

Targeting the androgen receptor in breast cancer. Curr Oncol Rep (2015) 0.83

Substance use among school-based youths in Puerto Rico: differences between gender and grade levels. Addict Behav (2004) 0.81